Statin Therapy and Outcome After Ischemic Stroke

s (no papers Reference searches

[1]  H. Kamel,et al.  Transcranial magnetic stimulation for tinnitus : No better than sham treatment ? , 2012 .

[2]  Anita Lukić,et al.  A Population-Based Prospective 24-Month Study of Stroke: Incidence and 30-Day Case-Fatality Rates of First-Ever Strokes in Croatia , 2012, Neuroepidemiology.

[3]  D. Blacker,et al.  A Randomized Placebo Controlled Trial of Early Treatment of Acute Ischemic Stroke with Atorvastatin and Irbesartan , 2012, International journal of stroke : official journal of the International Stroke Society.

[4]  P. Toth.  Statin Use During Ischemic Stroke Hospitalization Is Strongly Associated With Improved Poststroke Survival , 2012 .

[5]  W. Herrington.  Statin use and outcome after intracerebral hemorrhage: Case-control study and meta-analysis , 2011, Neurology.

[6]  G. Moretto,et al.  Does statin in the acute phase of ischemic stroke improve outcome after intravenous thrombolysis? A retrospective study , 2011, Journal of the Neurological Sciences.

[7]  R. Bordet,et al.  IV thrombolysis and statins , 2011, Neurology.

[8]  W. Ageno,et al.  Statins for acute ischemic stroke. , 2011, The Cochrane database of systematic reviews.

[9]  M. Zoli,et al.  The Atorvastatin During Ischemic Stroke Study: A Pilot Randomized Controlled Trial , 2011, Clinical neuropharmacology.

[10]  Samah W. Al-Jabi,et al.  Statin use prior to ischemic stroke onset is associated with decreased in‐hospital mortality , 2011, Fundamental & clinical pharmacology.

[11]  K. Furie,et al.  Statin Treatment and Functional Outcome After Ischemic Stroke: Case–Control and Meta-Analysis , 2011, Stroke.

[12]  L. Daly,et al.  Association Between Acute Statin Therapy, Survival, and Improved Functional Outcome After Ischemic Stroke: The North Dublin Population Stroke Study , 2011, Stroke.

[13]  S. Greenberg,et al.  Statin use and outcome after intracerebral hemorrhage , 2011, Neurology.

[14]  T. Sobrino,et al.  Toll-like receptors 2 and 4 in ischemic stroke: Outcome and therapeutic values , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[15]  R. Delgado-Mederos,et al.  Statin pretreatment may increase the risk of symptomatic intracranial haemorrhage in thrombolysis for ischemic stroke: results from a case–control study and a meta-analysis , 2011, Journal of Neurology.

[16]  M. Kaste,et al.  Post-Thrombolytic Hyperglycemia and 3-Month Outcome in Acute Ischemic Stroke , 2010, Cerebrovascular Diseases.

[17]  B. Norrving,et al.  Ischemic Stroke and Secondary Prevention in Clinical Practice: A Cohort Study of 14 529 Patients in the Swedish Stroke Register , 2010, Stroke.

[18]  M. Pittler.  Systematic Reviews in Health Care: Meta‐analysis in Context , 2010 .

[19]  J. De Keyser,et al.  Statin Use and Functional Outcome after Tissue Plasminogen Activator Treatment in Acute Ischaemic Stroke , 2010, Cerebrovascular Diseases.

[20]  M. Hennerici,et al.  Statin Treatment and Stroke Outcome in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial , 2009, Stroke.

[21]  Alex J Sutton,et al.  Statins for the prevention and treatment of infections: a systematic review and meta-analysis. , 2009, Archives of internal medicine.

[22]  M. Hajduk,et al.  Higher mean platelet volume determined shortly after the symptom onset in acute ischemic stroke patients is associated with a larger infarct volume on CT brain scans and with worse clinical outcome , 2009, Clinical Neurology and Neurosurgery.

[23]  G. Duckwiler,et al.  Impact of Hyperlipidemia and Statins on Ischemic Stroke Outcomes after Intra-Arterial Fibrinolysis and Percutaneous Mechanical Embolectomy , 2009, Cerebrovascular Diseases.

[24]  A. Kyritsis,et al.  Statin therapy after first stroke reduces 10-year stroke recurrence and improves survival , 2009, Neurology.

[25]  Robert D. Brown,et al.  Statins in ischemic stroke: just low-density lipoprotein lowering or more? , 2009, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[26]  E. García-Ramallo,et al.  Sex differences in the prognostic value of the lipid profile after the first ischemic stroke , 2009, Journal of Neurology.

[27]  E. Díez-Tejedor,et al.  The beneficial effect of statins treatment by stroke subtype , 2009, European journal of neurology.

[28]  Todd A. Durham,et al.  ntegrated Cardiac Safety: Assessment Methodologies for Noncardiac Drugs in Discovery, Development, and Postmarketing Surveillance , 2009 .

[29]  Z. Stelmasiak,et al.  Simvastatin inhibits the increase in serum tau protein levels in the acute phase of ischemic stroke. , 2008, Pharmacological reports : PR.

[30]  Z. Rumboldt,et al.  The Effect of Statin Pretreatment on Infarct Volume in Ischemic Stroke , 2008, Neuroepidemiology.

[31]  J. Gargano,et al.  Effect of Pretreatment With Statins on Ischemic Stroke Outcomes , 2008, Stroke.

[32]  L. Mascitelli,et al.  STATIN TREATMENT WITHDRAWAL IN ISCHEMIC STROKE: A CONTROLLED RANDOMIZED STUDY , 2008, Neurology.

[33]  G. Luijckx,et al.  Lipid profile, statin use, and outcome after intravenous thrombolysis for acute ischaemic stroke , 2008, Journal of Neurology.

[34]  C. Molina,et al.  Simvastatin in the acute phase of ischemic stroke: a safety and efficacy pilot trial , 2007, European journal of neurology.

[35]  J. Kuratsu,et al.  Low-dose of statin treatment improves cerebrovascular reactivity in patients with ischemic stroke: single photon emission computed tomography analysis. , 2008, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[36]  M. A. Moro,et al.  Statin treatment withdrawal in ischemic stroke , 2007, Neurology.

[37]  M. Gomis,et al.  Early Arterial Study in the Prediction of Mortality After Acute Ischemic Stroke , 2007, Stroke.

[38]  G. Duckwiler,et al.  Statin enhancement of collateralization in acute stroke , 2007, Neurology.

[39]  A. Thrift,et al.  Is prestroke use of angiotensin-converting enzyme inhibitors associated with better outcome? , 2007, Neurology.

[40]  T. Dalkara,et al.  Statin pre-treatment protects brain against focal cerebral ischemia in diabetic mice. , 2007, The Journal of surgical research.

[41]  C. Molina,et al.  Prior Statin Use May Be Associated With Improved Stroke Outcome After Tissue Plasminogen Activator , 2007, Stroke.

[42]  Adam J. Hoffhines,et al.  The discovery of aspirin's antithrombotic effects. , 2007, Texas Heart Institute journal.

[43]  D. Krieger,et al.  Statin Use is Independently Associated with Smaller Infarct Volume in Nonlacunar MCA Territory Stroke , 2006, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[44]  R. Califf,et al.  Statin Use and Sex-Specific Stroke Outcomes in Patients With Vascular Disease , 2006, Stroke.

[45]  R. Sacco,et al.  Lipid-lowering agent use at ischemic stroke onset is associated with decreased mortality , 2005, Neurology.

[46]  K. Lees,et al.  Statin administration prior to ischaemic stroke onset and survival: exploratory evidence from matched treatment–control study , 2005, European journal of neurology.

[47]  M. Fisher,et al.  HMG-CoA Reductase Inhibitors Improve Acute Ischemic Stroke Outcome , 2005, Stroke.

[48]  M. Moskowitz,et al.  Protective Effects of Statins Involving Both eNOS and tPA in Focal Cerebral Ischemia , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[49]  P. Touboul,et al.  Statins in Stroke Prevention and Carotid Atherosclerosis: Systematic Review and Up-to-Date Meta-Analysis , 2004, Stroke.

[50]  J. Martí-Fàbregas,et al.  Favorable Outcome of Ischemic Stroke in Patients Pretreated with Statins , 2004, Stroke.

[51]  S. Warach,et al.  Rising statin use and effect on ischemic stroke outcome , 2004, BMC medicine.

[52]  R. Collins,et al.  Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20 536 people with cerebrovascular disease or other high-risk conditions , 2004, The Lancet.

[53]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[54]  Yi Li,et al.  Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke , 2003, Annals of neurology.

[55]  E. Tremoli,et al.  Treatment With Statins After Induction of Focal Ischemia in Rats Reduces the Extent of Brain Damage , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[56]  MitsuhiroYokoyama,et al.  HMG-CoA Reductase Inhibitor Has Protective Effects Against Stroke Events in Stroke-Prone Spontaneously Hypertensive Rats , 2003 .

[57]  Barry R. Davis,et al.  Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT). , 2002, JAMA.

[58]  R. de Caterina,et al.  Statins and stroke: evidence for cholesterol-independent effects , 2002 .

[59]  M. Endres,et al.  Rosuvastatin, a new HMG-CoA reductase inhibitor, upregulates endothelial nitric oxide synthase and protects from ischemic stroke in mice , 2002, Brain Research.

[60]  M. Di Napoli,et al.  Inflammation, statins, and outcome after ischemic stroke. , 2001, Stroke.

[61]  M. Moskowitz,et al.  Mevastatin, an HMG-CoA reductase inhibitor, reduces stroke damage and upregulates endothelial nitric oxide synthase in mice. , 2001, Stroke.

[62]  Alex J. Sutton,et al.  Methods for Meta-Analysis in Medical Research , 2000 .

[63]  N. Delanty,et al.  Neuroprotective properties of statins in cerebral ischemia and stroke. , 1999, Stroke.

[64]  M. Moskowitz,et al.  Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[65]  A. Gotto,et al.  Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. , 1998, JAMA.

[66]  R. Westendorp,et al.  Cardioprotective effect of hormone replacement therapy in postmenopausal women: is the evidence biased? , 1994, BMJ.